You have read all your free articles, to continue reading subscribe to read the rest of this content.
The two companies have expanded their strategic biosimilar development partnership, which allows both companies to evaluate potential development and commercialization collaborations around Xbrane’s Xcimzane and Xdivane preclinical biosimilars and additional biosimilars that fit both companies’ Already a subscriber Login You have read all your free articles, to continue reading subscribe…
Medicon Valley Alliance is to welcome Novo Nordisk Scandinavia and General Manager & VP, Novo Nordisk Scandinavia, Niels Abel Bonde to the +300 member strong Danish-Swedish MVA-family. A strategic priority “We consider it a strategic priority to be a part of the Swedish and Medicon Valley baAlready a subscriber Login…
We would like to thank our readers, subscribers and collaboration partners for a fruitful, eventful and fun 2018, and we wish you all a most wonderful holiday season! Nordic Life Science will be back on January 2nd to provide you with the latest news from our exciting life science industry!…
Nanoform has announced the initiation of a technology evaluation of Nanoform’s CESS Technology across a range of AstraZeneca’s pharmaceutical products. The initiation of this study is to assess the added value that Nanoform’s technology could deliver across the pharmaceutical value chain. Already a subscriber Login You have read all your…
